The Fred Hutch Investigators in Novel Diagnostics for Cancer (FHIND Cancer) Research Group brings together investigators at Fred Hutchinson Cancer Center working in radiology, nuclear medicine, molecular and cell biology, biomarker science, pathology, molecular epidemiology, and data science to advance the discovery, validation, and clinical utility assessment of diagnostic technologies in order to realize the promise of precision oncology.